Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Cureus ; 15(11): e49280, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38143669

RESUMO

Background and objective It is crucial to make early differentiation between coronavirus disease 2019 (COVID-19) and seasonal influenza infections at the time of a patient's presentation to the emergency department (ED). In light of this, this study aimed to identify key epidemiological, initial laboratory, and radiological differences that would enable early recognition during co-circulation. Methods This was a retrospective, observational cohort study. All adult patients presenting to our ED at the Watford General Hospital, UK, with a laboratory-confirmed diagnosis of COVID-19 (2019/20) or influenza (2018/19) infection were included in this study. Demographic, laboratory, and radiological data were collected. Binary logistic regression was employed to determine features associated with COVID-19 infection rather than influenza. Results Chest radiographs suggestive of viral pneumonitis and older age (≥80 years) were associated with increased odds of having COVID-19 [odds ratio (OR): 47.00, 95% confidence interval (CI): 21.63-102.13 and OR: 64.85, 95% CI: 19.96-210.69 respectively]. Low eosinophils (<0.02 x 109/L) were found to increase the odds of COVID-19 (OR: 2.12, 95% CI: 1.44-3.10, p<0.001). Conclusions Gaining awareness about the epidemiological, biological, and radiologic presentation of influenza-like illness can be useful for clinicians in ED to differentiate between COVID-19 and influenza. This study showed that older age, eosinopenia, and radiographic evidence of viral pneumonitis significantly increase the odds of having COVID-19 compared to influenza. Further research is needed to determine if these findings are affected by acquired or natural immunity.

2.
Vet Parasitol Reg Stud Reports ; 41: 100887, 2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-37208076

RESUMO

The extensive livestock management system predominant in Nigeria necessitates active disease surveillance for the early detection and prompt control of transboundary animal diseases. Theileriae are obligate intracellular protozoa which infect both wild and domestic bovidae throughout much of the world causing East Coast Fever (Theileria parva), Tropical or Mediterranean theileriosis (Theileria annulata) or benign theileriosis (Theileria mutans; Theileria velifera). This study aimed to detect and characterize Theileria spp. infecting cattle in Nigeria using conventional PCR and sequencing approach. Five hundred and twenty-two DNA samples obtained from different cattle blood samples were subjected to PCR targeting the 18S rRNA gene of piroplasmida and specifically, the p104 kDa and Tp1 genes for the evidence of infection or vaccination respectively, with T. parva. A total of 269 out of 522 (51.5%) of the cattle tested PCR- positive for DNA of piroplasmida. Nucleotide sequence and phylogenetic analyses showed that the cattle were infected with T. annulata, T. mutans and T. velifera. Piroplasmida DNA was associated with sex (ꭓ2 = 7.2; p = 0.007), breed (ꭓ2 = 115; p = 0.000002) of animals and the state where the samples were collected (ꭓ2 = 78.8; p = 0.000002). None of the samples tested positive for T. parva DNA or showed evidence of vaccination (Tp1 gene). This is the first report on the molecular detection and characterization of T. annulata in the blood of cattle from Nigeria. Continuous surveillance of Nigerian cattle for East Coast Fever (ECF) is encouraged considering the recent report of the disease in cattle in the neighboring country, Cameroon, where unregulated transboundary cattle movement into Nigeria has been observed.


Assuntos
Piroplasmida , Theileria annulata , Theileria parva , Theileriose , Bovinos , Animais , Theileriose/epidemiologia , Theileriose/prevenção & controle , Theileria parva/genética , Theileria annulata/genética , Nigéria/epidemiologia , Filogenia
3.
Acta Parasitol ; 68(2): 430-438, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37170044

RESUMO

PURPOSE: The extensive migration practiced by pastoralists cattle exposes them to a variety of pathogens and vectors which may sometimes lead to severe disease outcomes. Moreover, the synergistic effect of multiple parasitism on the productivity of livestock has been well recognized. This is particularly true where the livestock production system predisposes the animals to constant and heavy infestation with arthropod vectors. METHODS: The presences, prevalence and risk factors for hemotropic Mycoplasma (hemoplasma) infection in cattle in Nigeria was investigated using a PCR and sequencing approach. DNA, extracted from 566 cattle blood samples, collected from 10 states from the three agro-ecological zones (AEZs) of Nigeria, from April 2021 to March 2022, were screened for the presences of hemotropic Mycoplasma spp. DNA. RESULTS: The DNA of hemoplasmas was detected in 48 out of the 566 (8.5%) samples, 12 (25%) of them were identified as Mycoplasma wenyonii and 19 (38.6%) as 'Candidatus Mycoplasma haemobos'. Coinfection with both species was detected in 17 (35.4%) of the samples. High prevalence and risk of hemoplasmas infection was associated with sex of the cattle (bulls were more affected; p = 0.005) and the packed cell volume (p = 0.009), but not with the age (p = 0.08), breed (p = 0.22), body condition (p = 0.052), source of the samples (p = 0.45) or the AEZs (0.59). This is the first nationwide survey of hemotropic mycoplasmas in cattle in Nigeria using this molecular approach. CONCLUSION: Further studies to determine the veterinary and public health significance of these pathogens, which were previously associated with varying degrees of clinical signs and production losses, are recommended in Nigerian cattle.


Assuntos
Doenças dos Bovinos , Infecções por Mycoplasma , Mycoplasma , Bovinos , Animais , Masculino , Infecções por Mycoplasma/epidemiologia , Infecções por Mycoplasma/veterinária , Infecções por Mycoplasma/diagnóstico , Nigéria/epidemiologia , Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/diagnóstico , Mycoplasma/genética , Gado , RNA Ribossômico 16S/genética
4.
Appl Biochem Biotechnol ; 195(6): 3966-3980, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35394253

RESUMO

High efficient and environment friendly one-pot in situ microwave irradiation method was implemented towards the preparation of porous reduced graphene oxide/WO3 (rGOW) nanocomposites for the first time. Here, 3D porous WO3 nanoparticles were evenly decorated on 2D rGO sheets. The crystal phase purity and the functional group characterizations of the as-synthesized nanomaterials were examined by powder XRD and Raman spectral analyses. The morphological studies from the SEM, TEM, and BET measurements clearly revealed the highly porous nature of nano-sized WO3 and its distribution on the surface of rigid 2D graphene sheet. The UV along with visible light-driven degradation mechanism of malachite green (MG) dye in the rGOW nanocomposites was well illustrated with the schematic diagram and discussed in detail through the kinetics of the degradation process upon calculating the rate constant and half-life time. The rGO/WO3 photocatalyst delivered high MG degradation efficiency of 97% under UV irradiation.


Assuntos
Grafite , Nanocompostos , Grafite/química , Porosidade , Óxidos/química
5.
Acta Trop ; 233: 106544, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35636526

RESUMO

Bovine anaplasmosis caused by Anaplasma marginale is an important endemic disease that exerts negative impact on livestock production with huge socioeconomic consequences in most developing countries. Genetic studies have reported the existence of diverse ntSTs of A. marginale with varying pathogenicity in different countries. Continuous studies to obtain accurate information on disease etiologies is desirable for the formulation of cost-effective control measures. To this end, 582 blood samples from cattle were collected from 10 out of the 36 States of Nigeria from April 2021 to March 2022 and analyzed based on the major surface protein 5 (msp5) gene to determine the ntSTs of A. marginale in Nigeria. In all, 38 out of the 582 samples (6.5%) from cattle in the different Agro-ecological Zones (AEZs) of Nigeria were positive. The Nigerian A. marginale nucleotide sequences were 96.7 to 100% identical to sequences from other countries and were placed in distinct clusters with other A. marginale sequences deposited in GenBank. Network analysis revealed three ntSTs (#2, #4 & #8) of A. marginale from Nigeria with a nucleotide sequence type diversity (Hd) of 0.8, nucleotide diversity (Pi) of 0.015 and average number of nucleotide differences (k) of 7.09. Two different amino acid substitution sites were found in Nigerian and worldwide sequences at positions 148 and 160. This is the first nationwide report on the ntST diversity and genetic characterization of A. marginale in cattle in Nigeria based on the msp5 gene. Bovine anaplasmosis is widespread in Nigeria and deserves further attention.


Assuntos
Anaplasma marginale , Anaplasmose , Doenças dos Bovinos , Anaplasma marginale/genética , Anaplasmose/genética , Animais , Proteínas da Membrana Bacteriana Externa/química , Proteínas da Membrana Bacteriana Externa/genética , Sequência de Bases , Bovinos , Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/genética , Nigéria/epidemiologia , Nucleotídeos , Filogenia
7.
Epilepsy Behav ; 127: 108537, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-35026562

RESUMO

OBJECTIVE: To assess the community's perception of epilepsy and its treatment in onchocerciasis-endemic villages of Maridi County, Western Equatoria State, South Sudan. The study was conducted prior to the setting up of a community-based intervention to manage the important disease burden caused by onchocerciasis-associated epilepsy in these villages. METHOD: Five focus group discussions (FGD) were conducted with community leaders and with persons with epilepsy (PWE) and their families between November and December 2019. RESULTS: Villages close to the Maridi dam were considered to be most affected by epilepsy. Misconceptions about the cause and treatment of epilepsy were identified. Most people believed that epilepsy is caused by bad spirits and is contagious, transmitted through saliva, air, and contact with PWE. Very few participants were aware of the link between onchocerciasis and epilepsy. Persons with epilepsy are restricted in their day-to-day activities and children with epilepsy are often denied going to school. Persons with epilepsy are stigmatized and seen as unfit for marriage. Most participants considered both traditional and medical treatment as ineffective. Uninterrupted anti-seizure treatment continuously was unaffordable for most families with one or more PWE. CONCLUSION: There is a need to establish a comprehensive epilepsy treatment program which addresses misconceptions about epilepsy and reduces epilepsy-related stigma. Explaining the link between onchocerciasis and epilepsy could lead to a reduction in epilepsy-related stigma.


Assuntos
Epilepsia , Oncocercose , Criança , Epilepsia/complicações , Epilepsia/epidemiologia , Epilepsia/terapia , Humanos , Oncocercose/complicações , Oncocercose/epidemiologia , Percepção , Convulsões/complicações , Sudão do Sul/epidemiologia
9.
Clin Infect Pract ; 12: 100095, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36338177

RESUMO

Infection expertise in the NHS has historically been provided predominantly by hospital-based medical microbiologists responsible for provision of diagnostic services and advice to front-line clinicians. While most hospitals had consultant-led microbiology departments, infectious iiseases departments were based in a small number of specialist centres. The demand for infection expertise is growing in the NHS, driven by advances in medical care, increasing awareness of the impact of antibiotic resistant and healthcare associated infections and threats from emerging infectious diseases. At the same time diagnostic services are being reorganised into pathology networks. The Combined Infection Training (CIT) is delivering a consultant workforce with expertise both in laboratory diagnostic practice and delivery of direct patient care. These changes create challenges for delivery of high quality infection expertise equitably across the NHS. They also offer an opportunity to shape infection services to meet clinical and laboratory demands. To date there has not been an attempt to bring together a single set of best practice guidelines for the requirements of an infection service. This document sets out seven standards. These are written to be practical and flexible according to the diverse ways in which infection expertise may be required across the NHS. It has been prepared by the Clinical Services Committee of the British Infection Association drawing on published evidence and guidance where they exist and on the group's extensive experience of delivering infection services in hospitals across the NHS. It was then refined with input from the RCP Joint Specialist committee (JSC) and the RCPath Specialist Advisory Committee (SAC) and through consultation with the RCPath membership. It has been endorsed by the Royal College of Pathologists and the Royal College of Physicians. It will be reviewed annually by the CSC and updated as additional evidence becomes available.

10.
Pract Neurol ; 18(4): 315-319, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29440316

RESUMO

Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis is a newly described, possibly under-recognised, severe inflammatory condition of the nervous system. The clinical presentation is variable but most commonly is a combination of meningitis, encephalitis and myelitis; other manifestations may include seizures, psychiatric symptoms and tremor. There is a significant association with malignancies, often occult, and with other autoimmune conditions. Although the disease responds well to corticosteroids acutely, it typically relapses when these are tapered, and so patients need long-term immunosuppression. We report a young man presenting with subacute meningoencephalitis and subsequent myelitis, and discuss the typical presentation and management of this severe but treatable condition.


Assuntos
Anticorpos/sangue , Proteína Glial Fibrilar Ácida/imunologia , Meningoencefalite/sangue , Mielite/sangue , Mielite/complicações , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Meningoencefalite/complicações , Meningoencefalite/diagnóstico por imagem , Meningoencefalite/terapia , Mielite/diagnóstico por imagem , Mielite/terapia , Troca Plasmática/métodos
11.
Frontline Gastroenterol ; 5(2): 111-117, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24683447

RESUMO

OBJECTIVE: Vertical transmission of the hepatitis B virus (HBV) is the commonest mode of infection and can be prevented with immunoprophylaxis of the infant and antiviral therapy in the mother. Our aim was to review a cohort of subjects with HBV in pregnancy to determine the prevalence of active disease or high HBV-DNA levels that required treatment to prevent transmission, and to review the management of mothers and infants. METHODS: A retrospective case-note review was conducted of all the HBV-infected pregnant women and their infants who attended the Newcastle obstetric services from 2007 to 2011. RESULTS: There were 113 pregnancies in 81 women (median age 28 years; 15% hepatitis B e antigen (HBeAg) positive) during 2007-11. 71% of mothers were first diagnosed with HBV during pregnancy. The mothers were born in 28 different countries. 69% of mothers had an HBV-DNA level less than 2000 IU/mL and 13% had HBV-DNA levels greater than 1.0×107 IU/mL so would be eligible for antiviral therapy to prevent transmission to the infant. 9% had active eAg-positive HBV and 3% had active eAg-negative HBV requiring treatment. All infants born to HBeAg-positive mothers received hepatitis B immunoglobulin (HBIG) appropriately and 76% of infants received a full HBV vaccination course. One infant born to an HBeAg-negative mother was hepatitis B surface antigen positive 1 year post-delivery. CONCLUSIONS: One in six women had active HBV requiring treatment or high HBV-DNA levels that would benefit from antiviral treatment to reduce the transmission risk. HBIG was administered appropriately but completion of the vaccination course was suboptimal.

13.
Expert Rev Anti Infect Ther ; 9(10): 891-9, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21973301

RESUMO

Hepatitis B virus (HBV) is a partially double stranded DNA virus that can integrate into host cell chromosomes as covalently closed circular DNA forms. HBV reactivation following hematopoietic stem cell transplantation in recipients with evidence of past HBV exposure, as well as exacerbation of a current HBV infection in HBV carrier recipients, secondary to chemotherapy and post-transplant immunosuppression that affect both humoral and cell-mediated control of HBV infection, are well documented in the literature. Management options include HBV-DNA screening and antiviral prophylaxis. Nucleos(t)ide analogues have been used at the start of chemotherapy and pretransplantation, with the course continuing for 6 months. However, depending on the serum HBV-DNA level, the antiviral agent might be given until a therapeutic end point is reached.


Assuntos
Antivirais/administração & dosagem , Transplante de Células-Tronco Hematopoéticas/métodos , Vírus da Hepatite B/efeitos dos fármacos , Hepatite B/tratamento farmacológico , Lamivudina/administração & dosagem , Infecções Oportunistas/tratamento farmacológico , Condicionamento Pré-Transplante/métodos , Antivirais/uso terapêutico , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/virologia , Linfócitos T CD8-Positivos/efeitos dos fármacos , Linfócitos T CD8-Positivos/virologia , DNA Viral/sangue , Gerenciamento Clínico , Esquema de Medicação , Hepatite B/sangue , Hepatite B/etiologia , Hepatite B/imunologia , Hepatite B/virologia , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/fisiologia , Humanos , Imunidade Celular/efeitos dos fármacos , Terapia de Imunossupressão/efeitos adversos , Lamivudina/uso terapêutico , Infecções Oportunistas/sangue , Infecções Oportunistas/etiologia , Infecções Oportunistas/imunologia , Infecções Oportunistas/virologia , Ativação Viral/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...